ORPEA

Earnings Release • May 6, 2009

PRESS RELEASE

Solidity and durability of growth Q1 2009 sales: +24% at €198.6m

Puteaux, 6th May 2009

ORPEA, a leading player in Long-Term Care (nursing homes), Post-Acute Care and Psychiatric Care, today announced its sales for the first quarter of 2009 to 31st March.

In €m IFRS	Q1 2009	Q1 2008	Δ
France	173.1	143.9	+20.3%
% of total sales	87%	90%
International	25.5	16.2	+57.1%
% of total sales	13%	10%
Belgium	11.9	4.4
Spain	6.9	6.3
Italy	4.3	3.6
Switzerland	2.4	1.9
Total sales	198.6	160.1	+24.0%
Organic growth			+11.0%

Yves Le Masne, Chief Operating Officer, commented: "ORPEA has recorded another quarter of buoyant growth, with sales up +24%. The Group is thus reaffirming the independence of its activity relative to the economic environment, as well as its structural ability to generate buoyant organic growth (+11%), combined with solid value-creating external growth.

Indeed, the occupancy rate is high for both mature facilities and for new rapidly-upramping facilities thanks to the quality of the buildings, their strategic locations, but also the commitment of the Group's teams, who are actively trained in permanently striving to improve the services and care provided to residents and patients.

Benefitting from substantial visibility on its activity, notably through a growth reservoir of close to 8,000 beds either under construction or being renovated, ORPEA has total confidence that it will meet its guidance in terms of 2009 sales (€820 million), 2011 sales (over a billion euros) and further solid profitability."

About ORPEA (www.orpea.com): Listed on Euronext Paris since April 2002 and elected to the Deferred Settlement Service, the ORPEA group is a leading player in the Long-Term Care and Post-Acute Care sectors. As of 1st March 2009, the Group has a unique European network of healthcare facilities, with 25,019 beds (20,540 of them operational) across 266 sites, including:

• 19,958 beds in France: 16,474 operational (including 2,774 being renovated) + 3,484 under construction, spread across 219 sites.
• 5,061 beds in Europe (Spain, Belgium, Italy and Switzerland): 4,066 operational (including 535 being renovated) + 995 under construction, spread across 47 sites.

Listed on Euronext Paris Compartment B of NYSE Euronext - ISIN: FR0000184798 Member of the SBF 120 index and SRD Reuters: ORP.PA - Bloomberg: ORP FP

Investor Relations

NewCap. ORPEA Emmanuel Huynh/Steve Grobet Yves Le Masne Tel: +33 (0)1 44 71 94 94 COO orpea@newcap.fr Tel: +33 (0)1 47 75 78 07